The Role of SGLT2 Inhibitors in Atherosclerosis: A Narrative Mini-Review

QR Code

The Role of SGLT2 Inhibitors in Atherosclerosis: A Narrative Mini-Review

Objective: Sodium glucose cotransporter 2 inhibitors (SGLT2-is) are antidiabetic drugs that improve glycemic control by limiting urinary glucose reuptake in the proximal tubule. SGLT2-is might suppress atherosclerotic processes and ameliorate the prognosis of patients with diabetes mellitus diagnose...

Description complète

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Aurélie Pahud de Mortanges, Dante Salvador Jr., Markus Laimer, Taulant Muka, Matthias Wilhelm, Arjola Bano
Format:	article
Langue:	EN
Publié:	Frontiers Media S.A. 2021
Sujets:	atherosclerotic cardiovascular disease SGLT2-inhibitors subclinical atherosclerosis diabetes review Therapeutics. Pharmacology RM1-950
Accès en ligne:	https://doaj.org/article/a3554c9245464d81943eb2087b792037
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Is cancer incidence modified by SGLT2 inhibitors?
par: Lev M. Berstein
Publié: (2019)

Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitors: A Clinician’s Guide
par: Simes BC, et autres
Publié: (2019)

SGLT2 inhibitors and the changing landscape for treatment of diabetes
par: Liu S, et autres
Publié: (2019)

Empagliflozin Alleviates Atherosclerosis Progression by Inhibiting Inflammation and Sympathetic Activity in a Normoglycemic Mouse Model
par: Liu Y, et autres
Publié: (2021)

Leptin and leptin receptor evaluation in atherosclerotic plaques in patients with type 2 diabetes mellitus
par: Diana A. Dimitrova, et autres
Publié: (2021)

12-month effects of incretins versus SGLT2-Inhibitors on cognitive performance and metabolic profile. A randomized clinical trial in the elderly with Type-2 diabetes mellitus
par: Perna S, et autres
Publié: (2018)

Comparison analysis of childhood body mass index cut-offs in predicting adulthood carotid intima media thickness: Tehran lipid and glucose study
par: Farhad Hosseinpanah, et autres
Publié: (2021)

Potential Mechanisms of SGLT2 Inhibitors for the Treatment of Heart Failure With Preserved Ejection Fraction
par: Steffen Pabel, et autres
Publié: (2021)

Glucose and other hexoses transporters in marine invertebrates: A mini review
par: Martínez-Quintana,José Alfredo, et autres
Publié: (2012)

ARYA atherosclerosis
Publié: (2005)

Role of endothelial cell specific molecule-1 (endocan) and cardiac imaging in early detection of cardiac involvement in psoriatic patients with or without arthritis
par: Salwa M.A. Ibrahim, et autres
Publié: (2022)

FMD and CIMT: Surrogate markers of atherosclerosis in subclinical and overt hypothyroidism in sub Himalyan Region
par: Bandana Kumari, et autres
Publié: (2021)

Effects of GLP-1RA and SGLT2i, Alone or in Combination, on Mouse Models of Type 2 Diabetes Representing Different Disease Stages
par: Masao Koike, et autres
Publié: (2021)

Comparative Analysis of the Preventive Effects of Canagliflozin, a Sodium-Glucose Co-Transporter-2 Inhibitor, on Body Weight Gain Between Oral Gavage and Dietary Administration by Focusing on Fatty Acid Metabolism
par: Kawarasaki S, et autres
Publié: (2020)

Antihypertensive and metabolic effects of empagliflozin in Ren-2 transgenic rats, an experimental non-diabetic model of hypertension
par: Silvie Hojná, et autres
Publié: (2021)

Mizagliflozin, a selective SGLT1 inhibitor, improves vascular cognitive impairment in a mouse model of small vessel disease
par: Nanae Ishida, et autres
Publié: (2021)

Canagliflozin review – safety and efficacy profile in patients with T2DM
par: Jakher H, et autres
Publié: (2019)

Sodium-Glucose Cotransporter-2 Inhibitors Improve Cardiovascular Dysfunction in Type 2 Diabetic East Asians
par: Muhammad Afzal, et autres
Publié: (2021)

Comprehensive Analysis of Adverse Events Associated With SGLT2is: A Meta-Analysis Involving Nine Large Randomized Trials
par: Mei Qiu, et autres
Publié: (2021)

Upregulation Of Renal GLUT2 And SGLT2 Is Involved In High-Fat Diet-Induced Gestational Diabetes In Mice
par: Jiang YK, et autres
Publié: (2019)

Morphological Irregularity of Unruptured Intracranial Aneurysms is More Related with Aneurysm Size Rather Than Cerebrovascular Atherosclerosis: A Case-Control Study
par: Qi P, et autres
Publié: (2021)

Empagliflozin in type 1 diabetes
par: Mathieu C, et autres
Publié: (2019)

Role of sodium glucose cotransporter-2 inhibitors in type I diabetes mellitus
par: Ahmadieh H, et autres
Publié: (2017)

Dapagliflozin in the treatment of patients with heart failure with reduced left ventricular ejection fraction – a practical approach
par: Jadwiga Nessler
Publié: (2021)

The Interplay of Vitamin D Deficiency and Cellular Senescence in The Pathogenesis of Obesity-Related Co-Morbidities
par: Abdulhadi Bima, et autres
Publié: (2021)

Journal Club: What Are the Implications of the Presence of Magnetic Resonance Imaging–Detected Erosions and Synovitis in Healthy People?
par: Rayan Najjar
Publié: (2021)

Subclinical Atherosclerosis Progression in Obese Children with Relevant Cardiometabolic Risk Factors Can Be Assessed through Carotid Intima Media Thickness
par: Monica-Simina Mihuta, et autres
Publié: (2021)

Atherosclerosis.
Publié: (2000)

STUDYING OF APPLICATION IMMUNOMODULATOR «GALAVIT» AT EXPERIMENTAL ATHEROSCLEROSIS
par: E. P. Turmova, et autres
Publié: (2012)

Scavenger Receptors and Atherosclerosis
par: RIGOTTI,ATTILIO
Publié: (2000)

Empagliflozin: a new strategy for nephroprotection in diabetes
par: Anton Ivanovich Korbut, et autres
Publié: (2017)

Intensification of glucose-lowering treatment in patients with diabetes mellitus type 2 on insulin therapy: Perspectives of dapagliflozin
par: Olga Yuryevna Sukhareva, et autres
Publié: (2016)

Emerging use of combination therapies for the management of type 2 diabetes – focus on saxagliptin and dapagliflozin
par: Yu H, et autres
Publié: (2017)

Relationship between β-hydroxybutyrate and the fat: protein ratio of milk during early lactation in dairy cows
par: García,CAC, et autres
Publié: (2015)

Efficacy and safety of canagliflozin in type 2 diabetes mellitus patients with biopsy-proven nonalcoholic steatohepatitis classified as stage 1–3 fibrosis
par: Seko Y, et autres
Publié: (2018)

A Clinical Study on the Association of Sodium-Glucose Cotransporter 2 Inhibitors and Acute Kidney Injury Among Diabetic Chinese Population
par: Shen L, et autres
Publié: (2021)

Second line therapy in type 2 diabetes: legacy effect activation
par: Ekaterina A. Shestakova
Publié: (2017)

Nanotechnology for Targeted Therapy of Atherosclerosis
par: Seyedmehdi Hossaini Nasr, et autres
Publié: (2021)

Involvement of Intestinal Goblet Cells and Changes in Sodium Glucose Transporters Expression: Possible Therapeutic Targets in Autistic BTBR T<sup>+</sup>Itpr3<sup>tf</sup>/J Mice
par: Caterina Franco, et autres
Publié: (2021)

Characterisation of Staphylococcus aureus isolated from cases of bovine subclinical mastitis in two Uruguayan dairy farms
par: de los Santos,R, et autres
Publié: (2014)